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Abstract 
Background: Despite a lack of supporting evidence, most surgeons recommend routine interval 
appendicectomy following successful non-operative treatment of an appendix mass in children. We 
aimed to compare routine interval appendicectomy with active observation. 
Methods: We did a multicentre randomised controlled study between June 2011 and December 2014 
at 21 specialist paediatric surgery centres. 106 children aged 3-15 years were assigned by weighted 
minimization to interval appendicectomy (n=52) or active observation (n=54) with minimisation for 
age, trial centre, gender and presence of a faecolith on imaging. Only children who presented with an 
appendix mass and were successfully treated without appendicectomy or other surgical intervention 
were eligible. Due to the nature of the interventions blinding was not possible. Primary outcome was 
incidence of histologically proven recurrent acute appendicitis (active observation group) and 
incidence of significant complications related to interval appendicectomy. Data were analysed on an 
intention to treat basis. The study is registered with ISRCTN (number 93815412). 
Findings: Incidence of histologically proven recurrent acute appendicitis in children under active 
observation was 12%, [95%CI 5, 23]. Incidence of significant complications related to interval 
appendicectomy was 6% [95%CI 1, 17%]. In the active observation group total 23% of children 
underwent appendicectomy within 1 year of enrolment. Time in hospital, time away from daily 
activities and cost were all lower with active observation than routine interval appendicectomy. 
Interpretation: These high quality data will allow clinicians, parents and children to make an evidence-
based decision regarding the justification for interval appendicectomy. 
Funding: the BUPA Foundation. 
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Background 
Acute appendicitis is the most common surgical emergency in children. The lifetime risk of 
developing appendicitis is 7-8% with a peak incidence in the second decade of life.1 Approximately 
9% of children with acute appendicitis present with a palpable, fixed, walled-off mass surrounding 
the inflamed appendix known as an appendix mass (AM).2 Treatment of the acute phase of AM in 
children is usually non-operative with broad spectrum intravenous antibiotics as the risk of 
complications from attempted appendicectomy in the presence of an inflammatory mass is high.3 
Following successful non-operative treatment, current surgical dogma is that interval 
appendicectomy (IA) should be performed in order to avoid future recurrence of acute appendicitis. 
However this approach has been questioned in both the paediatric 4 and adult literature.5 
When considering whether to perform interval appendicectomy or not in this clinical scenario, 
clinicians and parents must balance risks and benefits related to each management option. The main 
factors that contribute to the decision making process related to interval appendicectomy are the 
incidence of recurrent acute appendicitis following successful conservative treatment of appendix 
mass, the morbidity and risks associated with interval appendicectomy, the risk of missing an 
alternative diagnosis (such as carcinoid tumour) by not performing an interval appendicectomy, and 
the cost effectiveness of each method of treatment. Proponents of IA argue that the risk of 
recurrent appendicitis is high and that interval appendicectomy is safe, and has a low morbidity. 
Those who opt for conservative management cite the opposite: a relatively low incidence of 
recurrent appendicitis and avoidable morbidity, hospital stay and cost associated with IA. A survey of 
UK based paediatric surgeons in 2009 reported that 68% routinely recommend IA for all children.6 
Our systematic review of the available literature, published in 20117, estimated the risk of 
developing recurrent acute appendicitis following successful non-operative treatment of an 
appendix mass in children as 20%, and the incidence of complications after IA as 3%. A key finding of 
this review was the limited number of published studies, the majority of which were retrospective 
and of relatively poor methodological quality. Only three studies contributed data to the outcome of 
recurrent appendicitis,8-10 one of which suggested that the incidence of recurrent appendicitis was 
higher in children with a faecolith.9 
In order to determine if IA is justified we designed the CHildren’s INterval Appendicectomy (CHINA) 
study. This prospective, multicentre, randomised study aimed to generate high quality prospective 
data to allow clinicians, parents and patients to make an informed decision about the need for, and 
cost effectiveness of interval appendicectomy following successful non-operative treatment of 
appendix mass in children. 
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Methods 
Study design 
We performed a prospective, multicentre randomised study in which children who had had an 
appendix mass successfully treated non-operatively were allocated by weighted minimization to 
either routine interval appendicectomy or 1 year of active observation. Recruiting centres were 21 
specialist Paediatric Surgery Centres. Nineteen of these centres were in the United Kingdom, one in 
Sweden and one in New Zealand. Ethical approval was obtained in all centres prior to recruitment. 
The study was performed according to a single protocol. The study was registered with the ISRCTN 
registry in July 2011 (identifier 93815412) and is reported in accordance with CONSORT guidelines.11 
 
Participants 
Children (<16 years) who presented with acute appendicitis and an appendix mass were eligible for 
inclusion if they satisfied the following criteria:. diagnosis of acute appendicitis with appendix mass; 
appendix mass palpable clinically, during examination under anaesthetic or identified radiologically 
(ultrasound or CT); have been successfully treated non-operatively during the acute stage of the 
illness and discharged home 
 
Children were excluded from the study if they were aged less than 3 years at the time of initial 
presentation, had co-existing gastrointestinal disease (e.g. inflammatory bowel disease) or had a 
significant co-existing medical condition or immune defect 
 
No formal definition of an appendix mass was used, rather the diagnosis was made by the surgeon in 
charge of the child’s care based on any of: clinical examination, examination under anaesthesia or 
imaging (ultrasound and/or CT scan). Successful non-operative treatment was defined as the child 
being well enough to be discharged home on oral antibiotics having not undergone surgery or 
attempted surgery to remove the appendix nor received percutaneous drainage of any appendix 
related abscess. Children under 3 years were excluded due to the difficulty in making a reliable 
diagnosis of appendix mass in this age group. 
 
All participants were enrolled into the study following informed parental consent. The study was 
explained to the parents and child if appropriate (depending on age) with the help of a study 
information sheet. Separate, age specific, information sheets were provided to children aged 8-11 
years and those aged 12-15 years. Children aged 12 years or over were able to provide their own 
consent for participation if they wished, in addition to or in place of parental consent. 
 
Interventions 
Children were allocated to one of the following treatment groups: 
1. interval appendicectomy (IA)– children were scheduled to undergo elective IA (open or 
laparoscopic) at a timescale determined by the operating surgeon’s current practice, but 
with an advisory timescale of 2-3 months following randomisation. Children were reviewed 
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in the outpatient clinic at approximately 6 weeks following interval appendicectomy and 
again at 1 year following randomisation. 
 
2. active observation (AO) – children were not scheduled for routine IA but were reviewed 
every 3 months in the outpatient clinic for 1 year following randomisation. Any child that 
developed recurrent appendicitis or who had symptoms that in the opinion of the treating 
clinician warranted surgery, underwent appendicectomy by either open or laparoscopic 
approach at the surgeon’s discretion. 
 
Treatment allocation and masking 
Participants were allocated to groups (1:1 ratio) using weighted minimisation (randomisation 
weighting of 4) at the time of enrolment into the study using the following criteria: gender ([male], 
[female]), presence of faecolith on radiological investigation ([yes], [no]), age ([3-9yrs], [10-15yrs]), 
and collaborating centre. 
 
 
Minimisation was set up using an online computerised service provided by the University of 
Aberdeen, UK. This allowed for concealment of previously allocated patients from all site 
investigators  prior to allocation by minimization. Due to the nature of the interventions blinding was 
not possible. We included collaborating centre as one of the minimisation criteria to account for 
differences that may have existed in treatment approach between centres. We did not include 
individual surgeon as a minimisation criterion since the actual number of participants expected to be 
operated on by each individual surgeon was very low (less than 1 patient per surgeon where each 
surgeon from each participating centre was considered). Thus it is highly unlikely that treatment by 
any individual surgeon would influence study results. 
Outcomes 
Due to the different nature of the interventions in each treatment group the primary outcomes for 
each group were different. All outcomes were defined a priori. 
The primary outcome in the IA group was the incidence of significant complications during or 
following IA. Significant complication was defined as any complication requiring additional or 
unanticipated treatment including, but not limited to, intestinal perforation, haemorrhage requiring 
transfusion, wound infection requiring antibiotics, abscess formation, post-operative small bowel 
obstruction, prolonged ileus (>72hrs post-operatively). Conversion of a laparoscopic to open interval 
appendicectomy in the absence of another complication meeting the above definition was not 
defined as a significant complication. 
The primary outcome in the AO group was the proportion of children developing recurrent acute 
appendicitis within 1 year of enrolment following successful non-operative treatment of appendix 
mass. Recurrent acute appendicitis was defined as appendicitis confirmed by evidence of acute 
inflammation on histological examination of the resected appendix or a clinical diagnosis of 
recurrent appendix mass in the opinion of the consultant responsible for the child's care. The 
presence of acute inflammation was based upon consultant histopathologist report at each 
individual institution. 
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Secondary outcomes were selected on their ability to inform the aims of the study and were 
relevant to one or both treatment groups including: adverse events, duration of hospital admission 
related to the appendix during one year after enrolment, cost of treatment related to the appendix 
in one year follow up, days off school / normal daily activities related to the appendix in one year 
follow up, details of all surgical procedures performed, histopathological evaluation of any resected 
appendicectomy specimen. Whilst participant safety and serious adverse events were monitored in 
this study, neither were included as formal study outcomes since this study compared two 
treatments both of which are routinely used and considered standard of care. 
Data relating to all outcomes were recorded prospectively at the local centre and forwarded to the 
collaborating centre at completion of the study. Data related to hospital admission was recorded 
during or immediately following the admission. To capture data related to admission to another 
hospital during the 1 year follow-up period, participants were specifically asked whether they had 
had a hospital attendance or admission for abdominal pain or suspected appendicitis at follow-up 
consultations. At discharge from hospital, parents were provided with a diary card and asked to 
document days on which their child was unable to attend school or undertake normal daily activities 
during the follow-up period either due to hospital admission, recovery following hospital admission 
or unexplained abdominal pain. 
Total length of stay during the 1 year follow-up period was calculated for all planned and unplanned 
hospital admissions related to the appendix or abdominal pain at any hospital. 
Costs were obtained from each participating institution’s finance department for the cost of running 
the operating theatre for 1 hour (including staff costs) during 2015 and the cost of a 24 hour period 
on the paediatric surgical ward during 2015. Costs from international centres were obtained in local 
currency and converted into UK£ using the exchange rate on 31st December 2015. Cost related to 
hospital admission and time in the operating theatre were calculated by multiplying these units costs 
by time spent in hospital and time spent in the operating theatre respectively. Hospital admission 
cost and theatre cost were added to give a total cost per patient during the 1 year follow-up period. 
 
Sample size 
The study sample size was calculated to be able to demonstrate a statistically significant difference 
in the incidence of recurrent appendicitis between treatment groups based on of a 20% risk of 
recurrent acute appendicitis within the first year in the active observation group and a zero 
incidence in the interval appendicectomy group at 90% power. The sample size was set at 50 
children in each treatment group. 
 
Data handling and statistical analysis 
Data were collected locally by each centre and forwarded to the study coordinator at the end of the 
study. Data were entered into a custom designed database using Microsoft Access, exported into 
Microsoft Excel for handling and then analysed using statistical packages as detailed below. 
All data were analysed initially on an intention-to-treat basis. Due to some crossover between 
groups (see study profile, Figure 1), a secondary analysis was performed based on the treatment 
actually received. 
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Primary outcomes and other categorical data are reported as incidence with 95% confidence 
intervals (95% CI). Continuous data are reported as median with inter-quartile range (IQR). Between- 
group comparisons were made using Mann-Whitney U test for univariate analyses. Multiple linear 
regression analysis of log10(hours+1) and log10(cost +1) transformed data was performed as data 
were right skewed, adjusting for age, gender, faecolith and centre. Kaplan-Meier analysis was used 
to calculate recurrence risk over time and the log-rank test used to compare subgroups of children. 
Statistical analyses and generation of figures were performed using SPSS v22 (IBM Software) and 
Prism v6.0 (GraphPad software); p<0.05 was considered significant. 
 
Study oversight 
The study was overseen by a steering committee who met prior to recruitment of the first 
participant and regularly for the duration of the study and comprised the study co-ordinator (non-
voting), two independent paediatricians and an independent paediatric surgeon, with data provided 
and statistically analysed by SE (not involved in clinical care). The steering committee monitored 
recruitment to the trial, trial conduct and reviewed any protocol violations. The steering committee 
mandated that an interim analysis be undertaken after half of the sample size had been recruited 
and followed-up for one year. This interim analysis would calculate the rate of recurrent appendicitis 
and if found to be over twice that anticipated (i.e. over 40%) then the study would be terminated 
early. This interim analysis was performed as planned and the stopping rule not found to have been 
met. 
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RESULTS 
The trial profile is shown in Figure 1. Participants were enrolled in the study between August 2011 
and December 2014 with the first participant enrolled on August 8th 2011 and the final participant 
enrolled on December 31st 2014. The 1 year follow-up period for the final participant therefore 
ended on 31st December 2015. The study was open to recruitment in 21 centres with children 
actually enrolled in the study from 19 of these. A total of 183 children were screened and met the 
eligibility criteria in the recruiting centres during the study period. Of these, 106 children and/or 
their parents agreed to participate and were allocated to either IA or AO. 
Fifty-two children were allocated to IA. Of these, two children were withdrawn from the study due 
to withdrawal of consent for continued participation. Of the remaining 50 children, three more 
declined IA but were followed-up for 1 year, two developed recurrent appendicitis prior to their 
planned IA and one did not receive IA within the 1 year follow-up period. Therefore a total of 44 
children underwent IA during the study period. All 50 children allocated to the IA group who did not 
withdraw consent were analysed in the IA group on an intention to treat (ITT) basis. 
Fifty-four children were allocated to the AO group. Two children became ineligible following 
allocated and were therefore withdrawn from the study by local investigators: one who developed a 
second, unrelated medical condition early during the follow-up period that required several 
episodes of surgery and a second who developed an intra-abdominal abscess requiring re-admission 
and drainage 10 days after enrolment. The remaining 52 children were analysed in the AO group on 
an ITT basis. 
The baseline characteristics of the study groups are shown in Table 1. 
 
Of the 50 children allocated to the IA group and included in the ITT analysis, 44 children actually 
received IA during the study period. IA was performed at a median 66 days after treatment 
allocation (IQR 51-89). Significant complications related to IA occurred in 3 children (1 port site 
herniation with small bowel obstruction requiring laparotomy, 2 children with wound infection 
requiring antibiotics). The number of children meeting the protocol definition of the primary 
outcome (i.e. significant complication) for the IA group was 3/50 (6% [95%CI 1, 17%]). 
Of the 52 children in the AO group, 51 children received AO during the study period with a median 
duration of follow-up of 365 days (IQR 350-365) in those who did not undergo appendicectomy 
during follow-up. One child erroneously underwent IA without complications due to an 
administration error. Six children (12%, [95%CI 5, 23]) met the definition of primary outcome in the 
AO group in that they developed recurrent acute appendicitis and underwent appendicectomy with 
evidence of acute inflammation on histology. 
 
Secondary outcomes are reported in accordance with the protocol and are analysed initially on an 
ITT basis. 
 
In the IA group, 2 children developed recurrent appendicitis prior to their scheduled IA. One 
underwent laparoscopic appendicectomy, the other laparoscopic converted to open and one had a 
prolonged ileus (>72 hours). 
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Forty-four children allocated to IA actually received IA. Of these, 43 were performed using standard 
laparoscopy (including two conversion to open) and 1 using a single port technique.  Median 
duration of surgery was 66 minutes (IQR 55-88) and median duration of hospital stay related to IA 
(not including hospitalisation for complications) was 32 hours (IQR 28-48). Twenty-seven of the 44 
families returned post-discharge diary cards in whom the median time to return to school or normal 
daily activities after hospital discharge was 7 days (IQR 5-7). Histological reports were available for 
42 of the 44 surgical specimens, all of which contained appendiceal tissue, and revealed no 
inflammation in 15, acute inflammation in 8, chronic inflammation in 14, fibrosis in 17 and no 
carcinoid tumour. Other histological findings included threadworms (n=2), lymphoid hyperplasia 
(n=2), eosinophilic infiltration (n=1) and granuloma (n=1) in a child who had a subsequently negative 
diagnostic evaluation for Crohn’s disease. One minor adverse event was reported in the IA group in a 
child whose head was inadequately supported during anaesthesia. There was minor pain, but a 
satisfactory orthopaedic review and no sequelae. 
 
In total, 12 children in the AO group underwent appendicectomy. Six of these 12 had histologically 
confirmed recurrent acute appendicitis (the AO group primary outcome). Hospital stay related to 
recurrence was 105 hours (IQR 95-140). Two children had a laparoscopic appendicectomy, one 
laparoscopic converted to open appendicectomy and three open appendicectomy. Post-operative 
complications occurred in two children: wound infection (n=1) and prolonged (>72 hours) ileus (no 
further surgery, n=1). At follow-up (median 87 [IQR 56-135] days after recurrence) all six children 
were well but one had ongoing abdominal pain with exertion and one had unsatisfactory scar 
cosmesis. Histology demonstrated acute appendicitis in all 6, with a faecolith seen in two (both had 
been positively identified on imaging at time of initial presentation with appendix mass). In one 
specimen, part of the Fallopian tube that had been inadvertently excised along with the appendix 
was identified. 
During the follow-up period, a further five children in the AO group underwent appendicectomy for 
either suspected acute appendicitis (n=4) or ongoing abdominal pain (n=1). Histology was negative 
for acute inflammation in all, but revealed chronic inflammation (n=2), lymphoid hyperplasia (n=2) 
and serositis suggestive of an extra-appendiceal cause of inflammation (n=1). These children spent a 
median 50 hours in hospital (IQR 32-50) and all recovered without complication. Additionally, 5 
children had a hospital admission during the follow-up period for assessment of abdominal pain, all 
of which resulted in discharge home without appendicectomy. 
The final child in the AO who had appendicectomy had an elective IA due to an administration error. 
Seven of the 12 families returned post-discharge diary cards following appendicectomy in whom the 
median time to return to school or normal daily activities after hospital discharge was 7 days (IQR 2-
12). 
Cost and total duration of hospital stay related to appendicitis within 1 year from enrolment were 
compared between IA and AO groups, on intention to treat basis. Summary statistics for these 
parameters are shown in Table 2. Active observation was associated with a significantly shorter 
length of hospital stay and significantly lower cost than routine IA on univariate analysis. Multiple 
linear regression analysis was used to determine the relationship between treatment group and 
these outcomes taking into account the minimisation criteria of age, gender, presence of a faecolith 
and centre. Results are shown in Table 3. There was no significant effect of treatment centre on 
either total LOS or cost (data not shown). Children allocated to receive AO spent on average 10% of 
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the time in hospital that those allocated to IA during the first year after enrolment and the cost was 
on average 1% of those allocated to IA. Children with a faecolith spent on average 2.6 times longer in 
hospital as those without, and cost of treating these children was on average 6.3 times that of those 
without a faecolith. Children allocated to receive AO spent on average 10% of the time in hospital 
that those allocated to IA during the first year after enrolment and the cost was on average 1% of 
those allocated to IA. Children with a faecolith spent on average 2.6 times longer in hospital as those 
without, and cost of treating these children was on average 6.3 times that of those without a 
faecolith. 
Since not all children received their allocated intervention, a secondary analysis based on the 
treatment actually received was performed. Outcomes were compared for 45 children who 
underwent IA and 55 who received AO. Baseline characteristics between these groups were similar 
(Web Appendix page 2, Table A2). In the 45 children who actually received IA, 3 met the criteria for 
the primary outcome in that they developed a significant complication following IA, giving an 
incidence of 7% (95% CI 2, 19). In the AO group, 6/55 children developed histologically proven 
recurrent acute appendicitis within the 1 year follow-up period (incidence 11% [95% CI 5, 22]). A 
further 5 children underwent appendicectomy for acute or chronic abdominal pain. Therefore, a 
total of 11 children in the AO group underwent appendicectomy in the 1 year follow-up period (20% 
[95% CI 11, 33]). 
In this analysis both total length of hospital stay and cost were significantly lower in the AO group 
compared to IA group in both univariate and multivariate analysis. As in the ITT analysis there was a 
statistically significant relationship between presence of a faecolith and cost of treatment. These 
data are shown in the Web Appendix page 2, Tables A3 and A4. 
Finally we explored whether there was any difference in incidence of histologically proven recurrent 
appendicitis or appendicectomy within 1 year of enrolment in children allocated to AO (ITT) or 
receiving AO (PTR) depending on gender and presence of a faecolith. The incidence of both these 
outcomes was similar regardless of presence of faecolith and gender in both ITT (Web Appendix 
pages 3-4 Figures A1 and A2) and PTR analyses . 
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DISCUSSION 
This study was designed to generate high quality prospective data to inform the decision of whether 
interval appendicectomy is justified following successful non-operative treatment of an appendix 
mass in children. Data were acquired from a population of children who initially presented with an 
appendix mass, were successfully treated without appendicectomy (or any other appendix related 
procedure) and subsequently allocated to either 1 year of active observation or planned elective 
interval appendicectomy. The study design allows for truly comparative data to be obtained 
minimising the influence of bias that may exist if data were recorded from observational cohorts 
only. Treatment groups were well matched for age, gender and presence of a faecolith. 
The main results of our study are that in children under active observation, 12% developed 
histologically proven recurrent appendicitis and 23% had an appendicectomy within 1 year of 
randomisation. The presence of a faecolith had no influence on the frequency of either of these 
outcomes. Although interval appendicectomy carries a low complication rate (6%), complications 
may be significant including need for return to the operating theatre in 2%. Overall, the cost of AO is 
less than IA. 
Prior to embarking on this study we undertook a systematic review of the existing literature.7 The 
volume of relevant literature was small, with just 3 articles reporting on rate of recurrent 
appendicitis in this specific patient population.8-10 The overall weighted incidence of recurrence 
based on these previous data was 21%. In this prospective study we now report the incidence of 
recurrent appendicitis, as defined by histological examination of the appendix as 12%. 
Appendicectomy is a frequently performed procedure in general paediatric surgical practise and all 
surgeons were experienced in the procedure at the start of the study. Although our study confirms 
previous reports that interval appendicectomy is generally a safe procedure with low morbidity, it is 
noteworthy that one child in this study suffered the significant complication of laparoscopic port-site 
hernia requiring subsequent bowel resection. Two further children developed wound infections 
requiring treatment with antibiotics. Clearly, avoiding interval appendicectomy would have avoided 
exposure to these complications but carries the risk of recurrence. Unexpectedly, two children 
developed recurrent appendicitis prior to their planned IA having previously had complete 
resolution of symptoms of appendix mass. Most surgeons will delay IA by a number of months in 
order to allow peritoneal inflammation to subside following the initial presentation. Our study 
demonstrates that recurrence during this interval is certainly possible. 
Regarding missing an alternative diagnosis in children undergoing active observation, the most 
important in children is that of a carcinoid tumour of the appendix. No child in this study who 
underwent appendicectomy, whether planned or unplanned, was found to have a carcinoid tumour. 
Our previous systematic review estimated the risk of carcinoid tumour in this population as less than 
1% which is similar to previous series of appendicectomies.12 This figure is within the range of overall 
incidence in the general population of developing a carcinoid tumour at any site.13 
In this study we have shown the cost of AO to be significantly less than that of IA. Although we did 
not undertake a full cost effectiveness analysis, we included the most significant healthcare 
associated costs related to each treatment approach, including both scheduled and unscheduled 
hospital attendances and admissions. We did not, however, include costs related to visits to the 
general practitioner or other healthcare related costs. We acknowledge that with decreasing 
admission times related to interval appendicectomy the cost of IA may be reduced further. In this 
study centres were free to use their standard practice including day case surgery if appropriate. In 
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our analysis, both duration of hospitalisation and time spent away from normal daily activities were 
significantly less for children in the AO arm as opposed to IA. We did not include the additional effect 
of this on parental activity, for example days absent from work. These results are similar to a 
previous study that investigated the cost of interval appendicectomy following perforated acute 
appendicitis.14 
In addition to those children who had an appendicectomy during the 1 year follow-up period for 
histologically proven acute appendicitis, a further 5 children underwent appendicectomy for either 
acute or chronic abdominal pain. Histology of these appendices did not reveal acute inflammation. 
Thus a total of 11 children in the AO group underwent symptomatic appendicectomy. Despite this, 
over 75% of children under AO did not undergo appendicectomy within 1 year. This is likely to be a 
pragmatic statistic to use for the purposes of counselling parents. 
We did not detect an increased incidence of recurrent appendicitis in children who had a faecolith. A 
previous report suggested that a faecolith may increase the risk of recurrence9 and for this reason 
we specifically included it as one of the minimisation criteria. Of the 12 children with a faecolith 
allocated to AO, just 2 (17%) developed histologically proven recurrent appendicitis during the 
follow-up period and one additional child underwent appendicectomy for a second episode of acute 
right iliac fossa pain 6 months after enrolment; histology revealed lymphoid hyperplasia only with no 
inflammation, yielding an appendectomy rate of 25%. Interestingly, across both treatment groups, 
the cost of treating children with a faecolith was significantly higher than children without a 
faecolith. However, the additional cost associated with treating a child with a faecolith was less than 
the cost benefit of AO (compared to IA). 
The strengths of this study are principally in its design. To our knowledge this is the first prospective 
study to report on outcomes of children with an appendix mass and is also the only randomised 
study designed to address this important clinical question. The study was carried out at multiple 
centres making it likely that our findings are generalisable to the target population. The principal 
limitation is that children in the AO group were followed up for only 1 year whilst the risk of 
recurrent appendicitis or need for subsequent appendicectomy is clearly lifelong. We intend to 
follow these children up in the future for a total of 5 years following initial enrolment. An additional 
limitation is that we were unable to blind participants or observers to the allocated treatment due to 
the nature of the interventions. However all outcomes were assessed using predefined, objective 
criteria. In addition, recruiting surgeons did not have access to patient allocation data, aggregated 
data, or data other than individual patient data in the course of usual clinical care. 
In conclusion, this prospective randomised study has provided high quality data on which clinicians, 
parents and children can, for the first time, make an evidence-based decision regarding the 
justification for interval appendicectomy. In children who do not have routine interval 
appendicectomy the risk of recurrent histologically confirmed appendicitis is 12% in the first year 
and over 75% will have avoided appendicectomy one year later. Observation alone results in fewer 
days in hospital, fewer days away from normal daily activities and is cheaper than routine interval 
appendicectomy. 
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Table 1: Baseline characteristics of treatment groups 
 IA group (n=50) AO group (n=52) 
Age (years, median [IQR]) 9 [5-12] 8 [4-11] 
Male gender (n [%])) 25 [50%] 26 [50%] 
Presence of faecolith on imaging at initial presentation 
with appendix mass (n [%]) 
11 [22%] 12 [23%] 
Allocation to each treatment group within centre is shown in the Web Appendix, Table A1 page 1. 
 
 
 
 
Table 2: Comparison of total length of hospital stay in 1 year from enrolment and cost between 
treatment groups (ITT analysis) 
 Allocated treatment group 
p* 
 
Interval 
appendicectomy 
(n=50) 
Active 
observation 
(n=52) 
Total length of stay (hours) 32 (26-49) 0 (0-23) p<0.0001 
Cost (UK £) 1476 (1022-2211) 0 (0-444) p<0.0001 
Data are median (IQR); *Mann-Whitney Test 
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Table 3: Results of multiple linear regression analysis exploring relationship between treatment 
group and outcomes adjusting for minimisation factors (ITT analysis). Effect sizes are multiplicative 
compared with reference as regression analysis was performed on log-transformed data. 
    Adjusted effect size (95% CI) P 
Total hospital stay in 1 year follow-up (hours)  
Gender    
 Female    reference  
 Male    1.28 (0.67, 2.44) 0.46 
Presence of faecolith    
 No faecolith   reference  
 Faecolith   2.65 (1.11, 6.30) 0.03 
Age    
 Age (per year older)   0.93 (0.84, 1.03) 0.18 
Treatment group    
 IA   reference  
 AO   0.10 (0.06, 0.19) <0.0005 
Cost in 1 year of follow-up (UK £)  
Gender    
 Female    reference  
 Male    1.61 (0.50, 5.23) 0.42 
Presence of faecolith    
 No Faecolith   reference  
 Faecolith   6.23 (1.30, 30.2) 0.02 
Age    
 Age (per year older)   0.85 (0.70, 1.02) 0.08 
Treatment group    
 IA   reference  
 AO   0.01 (0.00, 0.02) <0.0005 
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Figure 1: Trial profile 
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Active observation versus interval appendicectomy following successful non-operative treatment of appendix 
mass in children: a randomised controlled evaluation 
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Table A1: Centres, principal investigators and numbers recruited 
Centre Principal 
investigator(s)* 
Total number 
enrolled at site 
Allocated 
to IA 
Allocated 
to AO 
Alder Hey Childrens Hospital, 
Liverpool, UK 
Harriet Corbett 15 7 8 
Birmingham Children’s Hospital, 
UK 
Ingo Jester, 
Girish Jawaheer 
14 6 8 
Southampton Children’s Hospital, 
Souathmpton, UK 
Michael Stanton 11 5 6 
Evelina Children’s Hospital, 
London, UK 
Masih Kader, 
Alireza Keshtgar 
9 5 4 
Karolinska Institutet, Stockholm, 
Sweden 
Jan F Svensson 9 5 4 
Queens Medical Centre, 
Nottingham, UK 
Brian Davies 7 4 3 
Leeds General Infirmary, Leeds, 
UK 
Emma Sidebotham 5 2 3 
Royal Belfast Hospital for Sick 
Children, Belfast, UK 
David Marshall, 
Irene Milliken 
5 3 2 
Royal Hospital for Sick Children, 
Edinburgh, UK 
Merril McHoney 4 2 2 
Chelsea and Westminster Hospital, 
London, UK 
Simon Clarke 4 2 2 
Norfolk and Norwich University 
Hospital, Norwich, UK 
Thomas Tsang 4 2 2 
Great Ormond Street Hospital, 
London, UK 
Agostino Pierro, 
Paolo de Coppi 
3 1 2 
John Radcliffe Hospital, Oxford, 
UK 
Hugh Grant 3 2 1 
Starship Hospital, Auckland, New 
Zealand 
James Hamill 3 1 2 
Royal Victoria Infirmary, 
Newcastle, UK 
Bruce Jaffray 3 2 1 
King’s College Hospital, London, 
UK 
Niyi Ade-Ajayi 3 1 2 
Royal Alexandra Children’s 
Hospital, Brighton, UK 
Kalidasan 
Varadarajan 
2 1 1 
Leicester Royal Infirmary, 
Leicester, UK) 
Haitham Dagash, 
Shawqui Noor 
1 1 0 
Addenbrookes Hospital, 
Cambridge, UK 
Stephen Farrell 1 0 1 
Royal London Hospital, London, 
UK 
Ashwini Joshi 0 0 0 
Hull Royal Infirmary, Kingston-
upon-Hull, UK 
Sanja Besarovic 0 0 0 
* if more than one principal investigator listed then PI changed during study period 
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Table A2: Baseline characteristics of treatment groups for comparison based on treatment actually 
received 
  IA group 
(n=45) 
AO group 
(n=55) 
Demographics   
 Age (years, median [IQR]) 9 [5-12] 8 [4-11] 
 Male gender (n[%]) 21 [47%] 28 [51%] 
 Presence of faecolith on imaging at initial 
presentation with appendix mass (n [%]) 
11 [24%] 12 [22%] 
 
Table A3 Comparative outcomes between treatment groups based on treatment actually received 
Comparative outcomes    
 Total length of stay (hours) 32 [27-48] 0 [0-17] <0.0001$ 
 Cost (UK £) 1482 [1149-2138] 0 [0-400] <0.0001$ 
$Mann-Whitney test 
 
Table A4: Results of multiple linear regression analysis exploring relationship between treatment group 
and outcomes adjusting for minimisation factors (PTR analysis). Effect sizes are multiplicative compared 
with reference as regression analysis was performed on log-transformed data. 
    Adjusted effect size (95%CI) P 
Total hospital stay in 1 year follow-up (hours)  
Gender    
 Female    reference  
 Male    1.23 (0.67, 2.26) 0.49 
Presence of faecolith    
 No Faecolith   Reference  
 Faecolith   2.28 (1.02, 5.09) 0.05 
Age    
 Age (per year older)   0.94 (0.86, 1.04) 0.23 
Treatment group    
 IA   reference  
 AO   0.09 (0.05, 0.15) <0.001 
Cost in 1 year of follow-up (UK £)  
Gender    
 Female    reference  
 Male    1.65 (0.57, 4.72) 0.35 
Presence of faecolith    
 No faecolith   reference  
 Faecolith   4.23 (1.04, 17.17) 0.04 
Age    
 Age (per year older)   0.87 (0.74, 1.04) 0.12 
Treatment group    
 IA   reference  
 AO   0.00(0.00, 0.01) <0.001 
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Figure A1: Incidence and timing of histologically proven recurrent appendicitis during 1 year follow-up 
(panel A) by presence of a faecolith (panel B) and gender (panel C) in children allocated to active 
observation (ITT analysis). Curves compared using log-rank test. 
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Figure A2: Incidence and timing of appendicectomy (any cause) during 1 year follow-up (panel A) by 
presence of a faecolith (panel B) and gender (panel C) in children allocated to active observation (ITT 
analysis). Curves compared by log-rank test 
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